• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Selskabsmeddelelse

Cell Impact in replacement agreement, receives 6 MSEK

Cell Impact
Download udgivelse

In 2024, Cell Impact entered into an agreement concerning flow plates, forming tools and fixtures with a European manufacturer, with a total contract value of SEK 18 million. Due to delays in the project, no products have been delivered to date. The parties have now agreed to replace the previous agreement with a new one, under which the customer will pay Cell Impact SEK 6 million for activities already carried out.

Under the original agreement, payment was to be made on an ongoing basis as compensation for delivered flow plates, but as project deliveries have been delayed, no such payments have been made. The new replacement agreement means that the customer, through two payments during the first half of 2026, will pay Cell Impact for work already performed, resulting in a SEK 6 million strengthening of the company's cash position for tools, fixtures and other work undertaken. After receiving SEK 1.3 million during the course of the work, this leaves undelivered products amounting to SEK 10.7 million under the original agreement, which the customer does not expect to be delivered under the current circumstances.

"The agreement is a sign of a good working relationship between us and the customer. Despite the project being affected by delays on the demand side, we are now strengthening our cash position. Moreover, there remains a joint ambition to resume product deliveries to an extent corresponding to the original agreement," says Daniel Vallin, CEO of Cell Impact.

Today's agreement will provide Cell Impact with an additional SEK 6 million in cash during the first half of 2026.

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.